查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595657

肺部給藥裝置市場：按產品類型、應用、分銷管道 - 2025-2030 年全球預測

Pulmonary Drug Delivery Devices Market by Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), Application (Asthma, COPD, Cystic Fibrosis), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，肺部給藥裝置市場估值為500.7億美元，預計到2024年將達到529.9億美元，複合年成長率為5.91%，預計到2030年將達到748.8億美元。

肺部給藥裝置旨在將藥物直接輸送到肺部，並為氣喘、慢性阻塞性肺病（COPD）和其他肺部疾病等呼吸系統疾病提供快速起效的系統。這些設備對於最大限度地減少全身副作用和提供標靶治療，同時增加肺部局部藥物濃度至關重要。應用範圍包括霧化器、定量吸入器 (MDI) 和乾粉吸入器 (DPI)，最終用途主要用於慢性呼吸道疾病患者、醫療機構和居家照護環境。該市場的成長是由呼吸道疾病盛行率上升、環境污染加劇以及全球人口老化（更容易患呼吸道疾病）所推動的。此外，提供連接和資料分析的智慧吸入器等技術進步為提高患者依從性和治療效果提供了巨大的機會。然而，成長可能會受到高開發成本、嚴格的監管核准以及非專利藥競爭等挑戰的阻礙。發展中地區缺乏意識和承受能力也阻礙了擴張。公司透過投資研發來開發更有效率、更具成本效益且易於使用的設備，讓自己脫穎而出。我們還可以透過整合物聯網功能並探索新的藥物配方以更有效地進行肺部輸送來開闢新的途徑。從區域來看，我們預計透過擴大我們在呼吸道疾病發病率迅速增加的新興市場的業務，獲得更高的成長潛力。此外，與醫療保健提供者合作並實施有關肺部輸送裝置的好處和使用的教育計劃可以幫助克服用戶的猶豫並提高採用率。因此，肺部給藥市場呈現出充滿希望的機會和固有挑戰的平衡，需要策略創新和有針對性的市場擴張努力。

主要市場統計
基準年[2023] 500.7億美元
預測年份 [2024] 529.9億美元
預測年份 [2030] 748.8億美元
複合年成長率（%） 5.91%

市場動態：快速發展的肺部給藥設備市場的關鍵市場洞察

供需的動態交互作用正在改變肺部給藥裝置市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球慢性呼吸道疾病增加
    • 數位或智慧型吸入器開發的使用迅速增加
    • 擴大轉向肺部給藥裝置作為替代途徑
  • 市場限制因素
    • 定價和監管問題
  • 市場機會
    • 肺部裝置的新技術進展
    • 治療設備上的醫療保健支出增加
  • 市場挑戰
    • 由於霧化顆粒沉積導致維修困難

波特五力：開拓肺部給藥裝置市場的策略工具

波特的五力框架是了解肺部給藥裝置市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解肺部給藥裝置市場的外部影響

外部宏觀環境因素在塑造肺部給藥裝置市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解肺部給藥裝置市場的競爭格局

對肺部給藥裝置市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣肺部給藥設備市場供應商的績效評估

FPNV 定位矩陣是評估肺部給藥設備市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃肺部給藥裝置市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對肺部給藥裝置市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性呼吸道疾病發生率上升
      • 由於數位或智慧吸入器的發展，使用量迅速增加
      • 增加使用肺部藥物輸送裝置作為替代途徑
    • 抑制因素
      • 定價和監管問題
    • 機會
      • 肺裝置的新技術進展
      • 治療設備的醫療費用增加
    • 任務
      • 氣溶膠顆粒沉積導致維護困難
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章肺部給藥裝置市場：依產品類型

  • 乾粉吸入器
  • 定量吸入器
  • 噴霧器

第7章肺部給藥裝置市場：依應用分類

  • 氣喘
  • 慢性阻塞性肺病
  • 囊腫纖維化

第8章肺部給藥裝置市場：按分銷管道

  • 醫院藥房
  • 零售藥房

第9章美洲肺部給藥裝置市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太肺部給藥裝置市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲肺部給藥裝置市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Adherium Limited
  • Aerogen Ltd.
  • AptarGroup, Inc.
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Celares GmbH
  • Cipla Inc.
  • Gilbert Technologies BV
  • GlaxoSmithKline PLC
  • Koninklijke Philips NV
  • MannKind Corporation
  • Novartis AG
  • Omron Corporation
  • Sunovion Pharmaceuticals Inc.
Product Code: MRR-035AB9C0DA4A

The Pulmonary Drug Delivery Devices Market was valued at USD 50.07 billion in 2023, expected to reach USD 52.99 billion in 2024, and is projected to grow at a CAGR of 5.91%, to USD 74.88 billion by 2030.

Pulmonary drug delivery devices are specialized systems designed to deliver medications directly to the lungs, thus offering a rapid onset of action for respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. These devices are essential as they provide targeted therapy, minimizing systemic side effects while enabling higher local drug concentrations in the lungs. The application scope encompasses nebulizers, metered-dose inhalers (MDIs), and dry powder inhalers (DPIs), with end-use predominantly among patients with chronic respiratory conditions, healthcare facilities, and home care settings. The market is poised for growth driven by rising prevalence of respiratory diseases, increasing environmental pollution, and an aging global population susceptible to respiratory issues. Furthermore, technological advancements such as smart inhalers, which provide connectivity and data analytics, offer tremendous opportunities for improvement in patient adherence and outcomes. However, growth can be hampered by challenges including high development costs, stringent regulatory approvals, and competition from generic products. Limited awareness and affordability issues in developing regions also constrain expansion. For businesses, investing in R&D to develop more efficient, cost-effective, and user-friendly devices can be a differentiator. Incorporating IoT-enabled features and exploring novel drug formulations for more efficient pulmonary delivery can also open new avenues. Geographically, expanding presence in emerging markets where the incidence of respiratory disorders is rapidly increasing could provide higher growth potential. Furthermore, partnerships with healthcare providers to implement educational programs on the benefits and usage of pulmonary delivery devices can help overcome user hesitancy and improve adoption rates. The pulmonary drug delivery market thus presents a balance of promising opportunities and inherent challenges, necessitating strategic innovation and targeted market expansion efforts.

KEY MARKET STATISTICS
Base Year [2023] USD 50.07 billion
Estimated Year [2024] USD 52.99 billion
Forecast Year [2030] USD 74.88 billion
CAGR (%) 5.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pulmonary Drug Delivery Devices Market

The Pulmonary Drug Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of chronic respiratory diseases globally
    • Surge in use of development of digital or smart inhalers
    • Increasing shift toward pulmonary drug delivery devices as alternate route
  • Market Restraints
    • Issues concerned with price and regulations
  • Market Opportunities
    • Emerging technological advancements in pulmonary devices
    • Increasing healthcare expenditure on therapeutic devices
  • Market Challenges
    • Difficulty in maintenance due to deposition of aerosolized particles

Porter's Five Forces: A Strategic Tool for Navigating the Pulmonary Drug Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pulmonary Drug Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pulmonary Drug Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pulmonary Drug Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pulmonary Drug Delivery Devices Market

A detailed market share analysis in the Pulmonary Drug Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pulmonary Drug Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pulmonary Drug Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pulmonary Drug Delivery Devices Market

A strategic analysis of the Pulmonary Drug Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pulmonary Drug Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Adherium Limited, Aerogen Ltd., AptarGroup, Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, Celares GmbH, Cipla Inc., Gilbert Technologies BV, GlaxoSmithKline PLC, Koninklijke Philips N.V., MannKind Corporation, Novartis AG, Omron Corporation, and Sunovion Pharmaceuticals Inc..

Market Segmentation & Coverage

This research report categorizes the Pulmonary Drug Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Dry Powder Inhaler, Metered Dose Inhaler, and Nebulizer.
  • Based on Application, market is studied across Asthma, COPD, and Cystic Fibrosis.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies and Retail Pharmacy Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of chronic respiratory diseases globally
      • 5.1.1.2. Surge in use of development of digital or smart inhalers
      • 5.1.1.3. Increasing shift toward pulmonary drug delivery devices as alternate route
    • 5.1.2. Restraints
      • 5.1.2.1. Issues concerned with price and regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging technological advancements in pulmonary devices
      • 5.1.3.2. Increasing healthcare expenditure on therapeutic devices
    • 5.1.4. Challenges
      • 5.1.4.1. Difficulty in maintenance due to deposition of aerosolized particles
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pulmonary Drug Delivery Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Dry Powder Inhaler
  • 6.3. Metered Dose Inhaler
  • 6.4. Nebulizer

7. Pulmonary Drug Delivery Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. COPD
  • 7.4. Cystic Fibrosis

8. Pulmonary Drug Delivery Devices Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Retail Pharmacy Stores

9. Americas Pulmonary Drug Delivery Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pulmonary Drug Delivery Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pulmonary Drug Delivery Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Adherium Limited
  • 3. Aerogen Ltd.
  • 4. AptarGroup, Inc.
  • 5. AstraZeneca PLC
  • 6. Boehringer Ingelheim International GmbH
  • 7. Celares GmbH
  • 8. Cipla Inc.
  • 9. Gilbert Technologies BV
  • 10. GlaxoSmithKline PLC
  • 11. Koninklijke Philips N.V.
  • 12. MannKind Corporation
  • 13. Novartis AG
  • 14. Omron Corporation
  • 15. Sunovion Pharmaceuticals Inc.

LIST OF FIGURES

  • FIGURE 1. PULMONARY DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PULMONARY DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PULMONARY DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PULMONARY DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PULMONARY DRUG DELIVERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PULMONARY DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. PULMONARY DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. PULMONARY DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023